News
Sponsored by Texas Instruments: Complex battery systems are becoming a power solution for a range of applications, heightening the demand for advanced BMS and battery energy storage systems.
Electrodes are conductors through which electricity enters or leaves a component in a circuit ... cell is determined by its chemistry. For example, a lithium-ion cell has a nominal voltage of ...
Despite its success in advanced melanoma, Bristol Myers Squibb’s fixed-dose PD-1/LAG-3 combo, Opdualag, failed to move the ...
BMS is paying $150 million upfront in cash and equity to kick off the alliance with another $3 billion in additional payments that will be forthcoming if the projects advance as hoped.
BioNTech SE and BMS have partnered for the global co-development and co-commercialization of BNT327 across numerous solid ...
BMS entered the radiopharma space via its $4.1 billion buyout of RayzeBio at the end of 2023. Unlike Novartis’ approved ...
Instead of homing in on PSMA—currently the most validated target in prostate cancer—BMS and Philochem will instead ...
A new drug developed by a mainland Chinese biotechnology company is effective in combating three types of cancer that currently have limited treatment options, according to a multinational study ...
Fabricated via thermal evaporation, the champion perovskite-perovskite-silicon triple-junction solar cell reached an ...
The phase 3 VALOR-HCM trial in adults with obstructive HCM eligible for a procedure called septal reduction therapy (SRT) met its primary endpoint, according to BMS. The aim of the study is to ...
13d
Pharmaceutical Technology on MSNBMS outlays $11bn to join BioNTech’s development of bispecific cancer drugThe deal will see BMS partner with BioNTech on a bispecific antibody candidate, dubbed BNT327, of which the latter company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results